Dong Cheng

Title: The Innovations of Dong Cheng

Introduction

Dong Cheng is a notable inventor based in Hockessin, DE (US). He has made significant contributions to the field of biochemistry, particularly in the modulation of cholesterol homeostasis. With a total of 2 patents, his work has implications for understanding and treating various metabolic disorders.

Latest Patents

Dong Cheng's latest patents include innovative methods and compounds aimed at inhibiting S1 protease. The first patent, titled "Modulators of SREBP processing," provides compounds, compositions, and methods for the inhibition of S1 protease and modulation of cholesterol homeostasis in a cell. The second patent, "Sterol-regulated Site-1 protease and assays of modulators thereof," offers assays for identifying modulators of Site-1 protease. This invention also includes expression constructs and transgenic cells that are useful for developing assays for Site-1 specific proteases.

Career Highlights

Throughout his career, Dong Cheng has worked with prestigious institutions, including the University of Texas System. His research has contributed to advancements in understanding cholesterol metabolism and its regulation.

Collaborations

Dong Cheng has collaborated with esteemed colleagues such as Michael S. Brown and Joseph L. Goldstein. Their joint efforts have furthered research in the field of cholesterol regulation and its associated pathways.

Conclusion

Dong Cheng's innovative work and patents reflect his dedication to advancing biochemistry and understanding cholesterol homeostasis. His contributions continue to influence research and potential therapeutic approaches in metabolic disorders.